Product Information
TESTOSTERONE 1.62% (2.5 G) PKT is a generic product labeled by Actavis Pharma, Inc., priced at $1.8182 per GM under NDC 00591292630. Its NADAC has been published 275 times since Jun 30, 2021.
FDA first approved this application on Apr 10, 2019. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
16.2 mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00591292630
Classification
Generic
Dosage Form
GEL
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONEApproval Type
Generic (ANDA)
FDA Application
ANDA204570FDA Approved
4/10/2019
TE Code
AB2
On Market Since
2/12/2021
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE 1.62% (2.5 G) PKT has been published 275 times since Jun 30, 2021, and over the history we have for it it has declined 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8182 per GM |
|---|---|
| All-time high | $3.9790 (Aug 11, 2021) |
| All-time low | $1.6776 (Nov 20, 2024) |
| 52-week high | $2.6729 |
| 52-week low | $1.7376 |
| Median price | $2.4441 |
| Average price | $2.5174 |
| Largest weekly change | +38.5% (Aug 21, 2024) |
| Weeks tracked | 275 |
| Tracking since | Jun 30, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Testosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE 1.62% (2.5 G) PKT?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE 1.62% (2.5 G) PKT, manufactured by Actavis Pharma, Inc., is $1.8182 per GM (NDC 00591292630), effective Sep 30, 2026.
How has the price of TESTOSTERONE 1.62% (2.5 G) PKT changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE 1.62% (2.5 G) PKT has declined 47.3%. It has been tracked across 275 weekly CMS publications since Jun 30, 2021.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE 1.62% (2.5 G) PKT?
Since Jun 30, 2021, the NADAC for TESTOSTERONE 1.62% (2.5 G) PKT has ranged from a low of $1.6776 (Nov 20, 2024) to a high of $3.9790 (Aug 11, 2021), with a median of $2.4441 per GM.
Are there cheaper alternatives to TESTOSTERONE 1.62% (2.5 G) PKT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TESTOSTERONE 1.62% GEL PUMP, is $0.4595 per GM — about 75% below TESTOSTERONE 1.62% (2.5 G) PKT.
Who manufactures TESTOSTERONE 1.62% (2.5 G) PKT?
TESTOSTERONE 1.62% (2.5 G) PKT (NDC 00591292630) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.